ARTICLE | Clinical News
Geron preclinical data
November 15, 2004 8:00 AM UTC
In a mouse model of ovarian carcinoma, GRN163L, a lipidated telomerase inhibitor, in combination with Taxol decreased tumor burden in 2 of 9 mice. Both GRN163L and Taxol given alone prevented tumor ...